The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...
The upcoming report from Vertex Pharmaceuticals (VRTX) is expected to reveal quarterly earnings of $3.99 per share, indicating a decline of 5% compared to the year-ago period. Analysts forecast ...
Chicago police are investigating after two people were reportedly stabbed and one person was shot during a large fight on the ...